SW · Healthcare

Santhera Pharmaceuticals Holding AG (SANN)

Biotechnology

Santhera Pharmaceuticals Holding AG (SANN) is listed on SW in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SANN

P/E ratio

18.00

Santhera Pharmaceuticals Holding AG (SANN) — FAQ

What is SANN's P/E ratio?

The price-to-earnings (P/E) ratio for Santhera Pharmaceuticals Holding AG (SANN) is 18.00 (data as of 2026-03-22).

Does Santhera Pharmaceuticals Holding AG pay a dividend?

Dividend yield is not available in the current snapshot for Santhera Pharmaceuticals Holding AG (SANN). Check the MyAverix Finance app for the latest dividend data.

What sector is Santhera Pharmaceuticals Holding AG in?

Santhera Pharmaceuticals Holding AG (SANN) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SANN listed on?

SANN is listed on SW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)